ARCHIVES

ASCO Says FDA Plan For ESA Management Will Burden Oncologists

This article is from The Cancer Letter archive.

Vol. 36 No. 08 | March 5, 2010

Download PDF Visit The Full Archive

Related Articles

Chemosensitivity, Resistance Assays Not Ready For Clinic, ASCO Tech Assessment Says

August 27, 2004

Erbitux Improves Survival In Advanced Colorectal Cancer

November 30, 2007

Letter to the Editor: Gensia Official Says No “Threat” Implied In Question Study

May 26, 1995

GYN Group: Open Surgery Would Cost More Lives Than Morcellation

July 25, 2014

ICCCR to Focus Its Efforts on Prevention Research

February 22, 1991

Cancer Informatics: NCI Calls On Users To Help Redesign Physician’s Data Query

February 13, 1998